This Week in Addiction Medicine from ASAM
By American Society of Addiction Medicine
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 100
Description
This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine. Intended to serve as an accompaniment to the ASAM Weekly newsletter or as a stand-alone resource, This Week covers recent publications in addiction medicine research.
| Episode | Date |
|---|---|
|
Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
|
Dec 09, 2025 |
|
Lead: Very Low Nicotine Content Cigarettes for Smoking Cessation: Examining a Facilitated Extinction Approach and Dosing Schedule
|
Dec 02, 2025 |
|
Lead: Fatal Opioid Overdoses by Historical and Contemporary Neighborhood-Level Structural Racism
|
Nov 25, 2025 |
|
Lead: State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23
|
Nov 18, 2025 |
|
Lead: Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine
|
Nov 11, 2025 |
|
Lead: States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24
|
Nov 04, 2025 |
|
Lead: Ultra-processed food addiction in a nationally representative sample of older adults in the USA
|
Oct 28, 2025 |
|
Lead: Alcohol Consumption Per Capita and Suicide: A Meta-Analysis
|
Oct 21, 2025 |
|
Lead: Measures of General Intelligence and Risk for Alcohol Use Disorder
|
Oct 14, 2025 |
|
Lead: Medications for Opioid Use Disorder Playbook
|
Oct 11, 2025 |
|
Lead: Cannabis Use During Pregnancy and Lactation
|
Sep 30, 2025 |
|
Lead: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study
|
Sep 23, 2025 |
|
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound
|
Sep 16, 2025 |
|
Lead: Evaluation of a Novel Patient-Centered Methadone Restart Protocol
|
Sep 09, 2025 |
|
Lead: Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process
|
Sep 02, 2025 |
|
Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting
|
Aug 26, 2025 |
|
Lead: Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD
|
Aug 19, 2025 |
|
Lead: Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial
|
Aug 12, 2025 |
|
Lead: Implementation Gaps in US Syringe Service Programs, 2022
|
Aug 05, 2025 |
|
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’
|
Jul 29, 2025 |
|
Lead: Did alcohol facilitate the evolution of complex societies?
|
Jul 22, 2025 |
|
Lead: Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients
|
Jul 15, 2025 |
|
Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing
|
Jul 08, 2025 |
|
Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits
|
Jun 24, 2025 |
|
Lead: Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
|
Jun 17, 2025 |
|
Lead: Bitter sensing protects Drosophila from developing experience-dependent cocaine consumption preference
|
Jun 10, 2025 |
|
Lead: Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons
|
Jun 02, 2025 |
|
Lead: Medicaid Unwinding and Changes in Buprenorphine Dispensing
|
May 28, 2025 |
|
Lead: Loneliness Among US Veterans With Problematic Substance Use: Results From the National Health and Resilience in Veterans Study
|
May 20, 2025 |
|
Lead: The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption
|
May 13, 2025 |
|
Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols
|
May 06, 2025 |
|
Lead: Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial
|
Apr 29, 2025 |
|
Lead: Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties
|
Apr 22, 2025 |
|
Lead: Hospital Addiction Consultation Service and Opioid Use Disorder Treatment
|
Apr 15, 2025 |
|
Lead: Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022
|
Apr 08, 2025 |
|
Lead: Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years
|
Apr 01, 2025 |
|
Lead: Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans
|
Mar 25, 2025 |
|
Lead: Association Between Telehealth Initiation Of Stimulant Therapy And New Substance Use Disorder Diagnoses
|
Mar 18, 2025 |
|
Lead: The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021
|
Mar 11, 2025 |
|
Lead: Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness
|
Mar 04, 2025 |
|
Lead: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
|
Feb 25, 2025 |
|
Lead: Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
|
Feb 19, 2025 |
|
Lead: Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders
|
Feb 11, 2025 |
|
Lead: Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
|
Feb 04, 2025 |
|
Lead: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
|
Jan 28, 2025 |
|
Lead: Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice
|
Jan 21, 2025 |
|
ASAM Weekly Special Episode: Dr. David Fiellin & Dr. Eric Strain sit down to discuss the concept of Treatment Refractory Addiction
|
Jan 14, 2025 |
|
Lead: Review of Evidence on Alcohol and Health
|
Jan 14, 2025 |
|
Lead: The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
|
Dec 17, 2024 |
|
Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students
|
Dec 10, 2024 |
|
Lead: Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine
|
Dec 04, 2024 |
|
Lead: Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study
|
Nov 19, 2024 |
|
Lead: Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity
|
Nov 05, 2024 |
|
Lead: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
|
Oct 29, 2024 |
|
Lead: Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
|
Oct 22, 2024 |
|
Lead: Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review
|
Oct 15, 2024 |
|
Lead: Cannabis Policy Impacts Public Health and Health Equity
|
Oct 08, 2024 |
|
ASAM Weekly Special Episode: Dr. Shannon Miller talks PAM-7 and his path to addiction medicine [From the ASAM 55th Annual Conference]
|
Sep 30, 2024 |
|
Lead: Risk of Incident Psychosis and Mania With Prescription Amphetamines
|
Sep 24, 2024 |
|
Lead: Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders
|
Sep 17, 2024 |
|
Lead: State-level racial and ethnic disparities in buprenorphine treatment duration in the United States
|
Sep 10, 2024 |
|
Lead: Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial
|
Sep 04, 2024 |
|
Lead: The Lancet Psychiatry Commission on youth mental health
|
Aug 27, 2024 |
|
Lead: Alcohol Consumption Patterns and Mortality Among Older Adults With Health-Related or Socioeconomic Risk Factors
|
Aug 20, 2024 |
|
Lead: Physician Reluctance to Intervene in Addiction: A Systematic Review
|
Aug 13, 2024 |
|
ASAM Weekly Special Episode: Rapid Initiation of Injection Naltrexone for OUD | Dr. Matisyahu Shulman & Dr. Adam Bisaga
|
Aug 06, 2024 |
|
Lead: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
|
Aug 06, 2024 |
|
Lead: Psilocybin desynchronizes the human brain
|
Jul 30, 2024 |
|
Lead: Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children
|
Jul 23, 2024 |
|
Lead: Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study
|
Jul 16, 2024 |
|
Lead: Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
|
Jul 09, 2024 |
|
Lead: Global status report on alcohol and health and treatment of substance use disorders
|
Jul 02, 2024 |
|
Lead: Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths
|
Jun 25, 2024 |
|
Lead: Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
|
Jun 18, 2024 |
|
Lead: Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
|
Jun 11, 2024 |
|
Lead: Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco
|
Jun 04, 2024 |
|
Lead: Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
|
May 28, 2024 |
|
Lead: Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment
|
May 21, 2024 |
|
Lead: Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States
|
May 14, 2024 |
|
Lead: Biomarkers of metal exposure in adolescent e-cigarette users
|
May 07, 2024 |
|
Lead: Association of regular opioid use with incident dementia and neuroimaging markers of brain health in chronic pain patients
|
Apr 30, 2024 |
|
Lead: Preventing deaths after prison release
|
Apr 23, 2024 |
|
Lead: Telling the story of the opioid crisis
|
Apr 16, 2024 |
|
Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
|
Apr 09, 2024 |
|
Lead: Epigenome-wide association study on methamphetamine dependence
|
Apr 02, 2024 |
|
Lead: Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults
|
Mar 26, 2024 |
|
Lead: Adolescent Δ8-THC and Marijuana Use in the US
|
Mar 19, 2024 |
|
Lead: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults
|
Mar 12, 2024 |
|
Lead: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine
|
Mar 05, 2024 |
|
Lead: Smoking changes adaptive immunity with persistent effects
|
Feb 27, 2024 |
|
Lead: Overdose mortality incidence and supervised consumption services
|
Feb 20, 2024 |
|
Lead: Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy
|
Feb 13, 2024 |
|
Lead: Polysubstance mortality trends in White and Black Americans during the opioid epidemic
|
Feb 06, 2024 |
|
Lead: First Trimester Use of Buprenorphine or Methadone
|
Jan 30, 2024 |
|
Lead: Trends in hallucinogen-associated emergency department visits
|
Jan 23, 2024 |
|
Lead: Adolescent Residential Addiction Treatment In The US
|
Jan 17, 2024 |
|
Lead: Benzodiazepine Discontinuation and Mortality
|
Jan 09, 2024 |
|
ASAM Weekly Top 10 Peer reviewed Scientific Publications of 2023
|
Dec 28, 2023 |
|
Lead: Examining the benefit of a higher maintenance dose of extended-release buprenorphine
|
Dec 19, 2023 |
|
Lead: Relationship between alcohol use and firearm-involved suicide
|
Dec 12, 2023 |